Clinical Trial Update: MDMA-Assisted Psychotherapy for Treatment Resistant PTSD in Adolescents [Phase 2]

View source ↗

Summary

A Phase 2 study of MDMA-assisted psychotherapy for treatment-resistant post-traumatic stress disorder in adolescents has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• MDMA (3,4-methylenedioxymethamphetamine)

Snippet

Sponsor: University of California, Los Angeles | Conditions: PTSD, Post Traumatic Stress Disorder, Adolescents | Phase 2 | Status: WITHDRAWN